Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 20;25(22):5450.
doi: 10.3390/molecules25225450.

Recent Advances in One-Pot Modular Synthesis of 2-Quinolones

Affiliations
Review

Recent Advances in One-Pot Modular Synthesis of 2-Quinolones

Wan Pyo Hong et al. Molecules. .

Abstract

It is known that 2-quinolones are broadly applicable chemical structures in medicinal and agrochemical research as well as various functional materials. A number of current publications about their synthesis and their applications emphasize the importance of these small molecules. The early synthetic chemistry originated from the same principle of the classical Friedländer and Knorr procedures for the preparation of quinolines. The analogous processes were developed by applying new synthetic tools such as novel catalysts, the microwave irradiation method, etc., whereas recent innovations in new bond forming reactions have allowed for novel strategies to construct the core structures of 2-quinolones beyond the bond disconnections based on two classical reactions. Over the last few decades, some reviews on structure-based, catalyst-based, and bioactivity-based studies have been released. In this focused review, we extensively surveyed recent examples of one-pot reactions, particularly in view of modular approaches. Thus, the contents are categorized as three major sections (two-, three-, and four-component reactions) according to the number of reagents that ultimately compose atoms of the core structures of 2-quinolones. The collected synthetic methods are discussed from the perspectives of strategy, efficiency, selectivity, and reaction mechanism.

Keywords: 2-quinolone; N-heterocycle; cascade; catalysis; drug; multi-component; one-pot.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Recent examples of functional molecules containing 2-quinolone scaffold.
Figure 2
Figure 2
Tautomerization between 2-quinolone and 2-hydroxyquinolone.
Figure 3
Figure 3
Overview of classical and recent approaches to 2-quinolones.
Scheme 1
Scheme 1
Synthesis of 2-quinolones by Pd-catalyzed reaction of 2-iodoanilines.
Scheme 2
Scheme 2
Synthesis of 4-aryl-2-quinolones through a sequential Heck reaction cyclization of methyl-β-(2-acetamidoaryl)acrylates 6 and aryl iodides 7.
Scheme 3
Scheme 3
Synthesis of 4-aryl-2-quinolones through a sequential Heck reaction/amination process of β-(2-bromoaryl) acrylamides 10 with aryl iodides 11.
Scheme 4
Scheme 4
Synthesis of 3-substituted 2-quinolones through a sequential Heck reaction/cyclization process of 2-iodoaniline 14 with dialkyl itaconates 15.
Scheme 5
Scheme 5
Pd/NiFe2O4-catalyzed one-pot synthesis of 4-aryl-2-quinolone derivatives.
Scheme 6
Scheme 6
Synthesis of 2-quinolones by tandem Pd(0)-catalyzed amination/aldol condensation of aryl halides with acetamides.
Scheme 7
Scheme 7
Synthesis of N-hydroxyquinolin-2(1H)-ones through a sequential Buchwald-type amidation/cyclization process with PMB (p-methoxybenzyl)-protected N-hydroxyamides.
Scheme 8
Scheme 8
Synthesis of 2-quinolinones by Pd-catalyzed C–S activation/aryne insertion/intramolecular C–N coupling reaction.
Scheme 9
Scheme 9
Synthesis of quinolones by Pd-catalyzed oxidative annulation between acrylamides and aryne precursors.
Scheme 10
Scheme 10
Synthesis of quinolin-2(1H)-ones by a Pd-catalyzed C–H activation/C–C bond formation/intramolecular cyclization reaction.
Scheme 11
Scheme 11
Synthesis of 4-aryl-2-quinolones through a sequential Heck reaction/intramolecular amidation process of cinnamides possessing 2-(pyridin-2-yl)ethanamine with aryl iodides.
Scheme 12
Scheme 12
Copper iodide-catalyzed synthesis of 2-quinolones via cascade reactions of 2-halobenzocarbonyls with 2-arylacetamides.
Scheme 13
Scheme 13
Preparation of 3-amido-2-quinolones using a dendritic Cu powder.
Scheme 14
Scheme 14
Radical cyclization toward substituted 2-quinolone derivatives.
Scheme 15
Scheme 15
Synthesis of 2-quinolones via Cu-mediated C–H/N–H annulation.
Scheme 16
Scheme 16
Synthesis of 3-aryl-2-quinolones by alkyne activation with Ag(I) catalyst.
Scheme 17
Scheme 17
Ru-catalyzed annulation of anilides with acrylates or propiolates.
Scheme 18
Scheme 18
Rh-catalyzed synthesis of 3,4-cycloalkaquinolones using N-alkoxyamides and boronic esters.
Scheme 19
Scheme 19
Rh-catalyzed decarbonylative coupling reaction.
Scheme 20
Scheme 20
Microwave-assisted, solvent-free synthesis of substituted 2-quinolones by reaction of o-aminoarylketones with esters.
Scheme 21
Scheme 21
Ir-catalyzed cascade reaction using carbamoyl chlorides and internal alkynes.
Scheme 22
Scheme 22
Ni–Al cooperative bimetallic catalysis with arylformamides and internal alkynes.
Scheme 23
Scheme 23
Friedländer reaction by basic mesoporous catalysts.
Scheme 24
Scheme 24
Friedländer reaction by bifunctional zeolites as Lewis and Brønsted acid catalyst.
Scheme 25
Scheme 25
Synthesis of 3,4-disubstituted 2-quinolones by one-pot condensation promoted by microwave irradiation.
Scheme 26
Scheme 26
DMAP-catalyzed cyclization of Boc-anhydride of 2-alkenylanilines.
Scheme 27
Scheme 27
Formation of 2-quinolones in reaction between 4-nitroketones and hydrazines.
Scheme 28
Scheme 28
Synthesis of quinolones by reaction of 2-substituted indoles with 2-nitroalkenes under PPA.
Scheme 29
Scheme 29
DBU-promoted annulation using o-acetamidoacetophenones and carbon dioxide.
Scheme 30
Scheme 30
Lactamization of 2-alkenylanilines toward substituted 3,4-substituted 2-quinolones.
Scheme 31
Scheme 31
Palladium-catalyzed annulation of terminal alkynes.
Scheme 32
Scheme 32
Palladium-catalyzed annulation of internal alkynes.
Scheme 33
Scheme 33
Carbonylative [3+2+1] annulation by C–H activation.
Scheme 34
Scheme 34
Annulation of N-substituted o-iodoanilines.
Scheme 35
Scheme 35
Microwave-assisted carbonylative cyclization.
Scheme 36
Scheme 36
Regioselective synthesis of 3-substituted 2-quinolone using Pd@PS.
Scheme 37
Scheme 37
Cascade alkenyl aminocarbonylation and intramolecular aryl amidation.
Scheme 38
Scheme 38
Synthesis of 4-aryl-2-quinolinones in the presence of CO2 gas.
Scheme 39
Scheme 39
C–H activation of anilines with alkynes and CO gas.
Scheme 40
Scheme 40
Rh-catalyzed aerobic oxidative cyclization of simple anilines with internal alkynes.
Scheme 41
Scheme 41
Synthesis of 2-quinolinone by Ir-catalyzed three-component reactions.
Scheme 42
Scheme 42
Cu-powder-catalyzed one-pot synthesis of 3- and/or 4-substituted 2-quinolones.
Scheme 43
Scheme 43
Synthesis of multisubstituted 2-quinolones via four-component reaction.
Scheme 44
Scheme 44
McCluskey’s studies on four-component reaction.
Scheme 45
Scheme 45
Preparation of 2-quinolones using four-component adduct via Heck reaction.
Scheme 46
Scheme 46
π-Acid-catalyzed cyclization of four-component adducts containing alkynes.
Scheme 47
Scheme 47
Preparation of indoloquinolones using four-component reaction and C–H activation.
Scheme 48
Scheme 48
Synthesis of indoloquinolones via double N–H/C–H activation.
Scheme 49
Scheme 49
Ligand-controlled regioselective synthesis of 3,4-fused-2-quinolones.

Similar articles

Cited by

References

    1. Pham T.D.M., Ziora Z.M., Blaskovich M.A.T. Quinolone antibiotics. Med. Chem. Commun. 2019;10:1719–1739. doi: 10.1039/C9MD00120D. - DOI - PMC - PubMed
    1. Xing G., Pan L., Yi C., Li X., Ge X., Zhao Y., Liu Y., Li J., Woo A., Lin B., et al. Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent β2-adrenoceptor agonists. Bioorg. Med. Chem. 2019;27:2306–2314. doi: 10.1016/j.bmc.2018.10.043. - DOI - PubMed
    1. Aparici M., Carcasona C., Ramos I., Montero J.L., Otal R., Ortiz J.L., Cortijo J., Puig C., Vilella D., De Alba J., et al. Pharmacological profile of AZD8871 (LAS191351), a novel inhaled dual M3 receptor antagonist/β2-adrenoceptor agonist molecule with long-lasting effects and favorable safety profile. J. Pharmacol. Exp. Ther. 2019;370:127–136. doi: 10.1124/jpet.118.255620. - DOI - PubMed
    1. Ramos I., Aparici M., Letosa M., Puig C., Gavaldà A., Huerta J.M., Espinosa S., Vilella D., Miralpeix M. Abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, has a fast association rate and long residence time at receptor. Eur. J. Pharmacol. 2018;819:89–97. doi: 10.1016/j.ejphar.2017.11.043. - DOI - PubMed
    1. Ge X., Woo A.Y.-H., Xing G., Lu Y., Mo Y., Zhao Y., Lan Y., Li J., Yan H., Pan L., et al. Synthesis and biological evaluation of β2-adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffold. Eur. J. Med. Chem. 2018;152:424–435. doi: 10.1016/j.ejmech.2018.04.041. - DOI - PubMed

MeSH terms

LinkOut - more resources